Dr. Anand K., Managing Director & CEO, Agilus Diagnostics Ltd said, “As India approaches the 2026 Union Budget, diagnostics stands at the core of strengthening the nation’s healthcare backbone. Diagnostics informs nearly every clinical decision and policy choices have a direct bearing on patient outcomes, system efficiency and long-term costs Recent budgets have signalled intent with increased allocations—over ₹95,000 crore for health and ₹20,000 crore for research.
The next step is targeted execution. A key priority should be structural issues like the inverted duty regime, where importing finished diagnostic products is often cheaper than sourcing raw materials locally. This weakens domestic manufacturing and limits value creation within the country. More balanced tax structures supported by consistent R&D incentives can ease import dependence and make diagnostics more affordable. This must be done while maintaining quality and trust in the system.
As diagnostics increasingly adopt advanced technologies including AI-enabled tools, regulatory clarity and scientific validation will be critical to ensure safety and trust. At the same time, a patient centric approach must remain central. When diagnostics are accessible, accurate and locally produced, the benefits flow across the healthcare system A forward-looking budget can position diagnostics as a strategic pillar of preventive, affordable, and outcome-driven care in India.”

